Physicians are not only becoming more proficient with EHRs, they are using their systems for more than just reference. That's the conclusion of a new Accenture survey of more than 2,600 doctors in Australia, Brazil, England, Norway, Singapore and the U.S.
A Cambridge startup called Vaxxas that’s developing vaccines worn on the skin as patches just raised a $20 million Series B. The funding will be used to bring its Nanopatch platform to clinical trial, and to flesh out its pipeline of needle-free vaccines. The Nanopatch works by riling up the immune cells just below the skin’s surface, inducing […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
By now, most people have heard of the concept of self-driving cars. That’s perhaps in the not-too-distant future. But in the nearer term, there very well could be self-driving hospitals beds. Medical Xpress reports that a “Flexbed” is currently in the works by a team at the UTS Centre for Health Technologies in Australia, in […]
Genes can still be patented in Australia, thanks to a recent ruling by the country’s federal court. The court determined last year that companies can patent human genes – particularly Myriad Genetics’ patent on breast cancer-associated gene BRA1 – and on Sept. 5 shot down an appeal that said such a ruling limits genetic testing options […]
In The Diving Bell and the Butterfly, Jean-Dominique Bauby, who has locked-in syndrome, must listen to his nurse recite the letters of the alphabet and blink to the corresponding letter to spell out each of his responses. It’s a time-consuming and painstaking process that fills much of their days and causes fatigue, but it does […]
GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier Therapy, which it claims can reduce blood-sugar levels and offer weight-loss results in Type 2 Diabetes patients, has raised $34,755,000 in equity and CDIs, according to a regulatory filing it made with the SEC on July 22. The company still seeks $17,745,000, which […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
For efforts to promote breastfeeding, making sure that a hospital follows so-called baby-friendly practices is more important than whether it is formally accredited by a breastfeeding initiative, according to a new study. Australian researchers found that new mothers were more likely to be breastfeeding their newborns a few months after delivery if their hospitals followed the Baby-Friendly Hospital Initiative (BFHI) guidelines, than if they gave birth in a hospital accredited by the Initiative.
Australian company Cavitus is eyeing North Carolina's Research Triangle Park region as a possible site to relocate its headquarters. The company is planning the move to be closer to existing customers and to find new ones in the pharmaceutical industry. Other cities in the running include Boston and Chicago.
St. Jude Medical says it's won approval to begin selling its Athena deep brain stimulation programming device Down Under.
Sunshine Heart Inc. has raised $9.4 million, including $3.5 million from the sale of equity and options in the United States, according to documents filed with the Securities and Exchange Commission. The company, based in Australia and Eden Prairie, Minnesota, says it will use the money to fund a 20-patient feasibility study and eventually a large pivotal clinical trial in America of its C-Pulse technology, which helps hearts that are failing pump more blood.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Drug reformulation company iCeutica has raised nearly $2.6 million, according to a Securities and Exchange Commission filing. iCeutica uses its “SoluMatrix” technology to reformulate drugs for pharmaceutical clients. Companies typically reformulate drugs in order to protect patents that are in danger of expiring or to introduce a new delivery method, such as administering the drugs […]
Perrigo Co. has reached a $48 million agreement to acquire an Australian over-the-counter, store-brand pharmaceuticals supplier. Perrigo, which bills itself as the world’s largest manufacturer of over-the-counter drugs for the store-brand market, says the purchase of Orion Laboratories Pty Ltd. will add about $30 million annually to its sales, according to a statement from Perrigo. […]